|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 02, 2018 ) The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, proton pump inhibitors, sucralfate, and misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.
Read the report at
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2018
The substantial growth of the market from $55 billion in 2017 to close to $67 billion by 2021 is due to the expected increase in prevalence of obesity and digestive diseases globally.
In the report, the global gastrointestinal drugs market is divided into six segments, namely, antiulcerants, vitamin and minerals, antacids, antiemetics and antinauseants, antiobesity and antidiarrhoeals. While the first and the second segment accounts for over four-fifth of the market and the remaining share is accounted by the other four segments.
Download a sample of the report at
https://www.thebusinessresearchcompany.com/sample.aspx?id=252&type=smp
The USA was the largest country in the gastrointestinal drugs market in 2017, accounting for 15% of the market share. This can be attributed to the high prevalence of obesity and digestive diseases such as ulcers in the country. Japan and China followed the USA as the next largest countries in the market.
The gastrointestinal drugs market is fragmented with a number of large and small organizations. The top five competitors in the market made up nearly 25% of the total market in 2017. Takeda Pharmaceuticals was the largest competitor of the market, followed by Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc. and Johnson & Johnson. Takeda is a pharmaceutical company which develops, manufactures and sells medications in various therapeutic areas including oncology, gastroenterology, central nervous system, vaccines and others. The company is headquartered in Osaka, Japan.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
The Business Research Company
Marketing TBRC
+91 8897263534
Marketing@tbrc.info
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
